BOOP pneumonia, formally known as bronchiolitis obliterans organizing pneumonia, is a lung condition in which small plugs of inflammatory tissue form inside the airways and air sacs, blocking normal breathing. The name has largely been replaced in medical literature by “cryptogenic organizing pneumonia” (COP) when no underlying cause is found, but many patients and even some clinicians still use the BOOP label. Despite its alarming name, the condition generally responds well to corticosteroid treatment, though relapses are common enough that they shape how doctors manage the disease over months or even years.
Why the Name Changed
BOOP was first described as a distinct clinical entity in the early 1980s and is classified as a rare idiopathic interstitial pneumonia.1PubMed. Cryptogenic Organizing Pneumonia The original name caused persistent confusion because “bronchiolitis obliterans” on its own refers to a different, more severe condition that involves permanent scarring and narrowing of the small airways. In contrast, the organizing pneumonia pattern in BOOP involves loose plugs of tissue inside the airspaces that can be reversed with treatment. To avoid mix-ups, the medical community began favoring “cryptogenic organizing pneumonia” for idiopathic cases and “secondary organizing pneumonia” when a known trigger exists. You will still see “BOOP” used interchangeably in older literature and patient-facing materials, so knowing both terms helps when reading about it.
What Happens Inside the Lungs
The hallmark of BOOP is the growth of small buds of granulation tissue, called Masson bodies, inside the alveoli, alveolar ducts, and terminal bronchioles.2European Respiratory Review. Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease These tissue plugs do not destroy the underlying lung architecture the way scarring diseases do. Instead, they fill the airspaces and interfere with gas exchange, which is why breathing becomes difficult. The process unfolds in stages: first, inflammatory cells and clotting factors cluster inside the air sacs; then fibroblasts migrate in, multiply, and start laying down a loose connective matrix; finally, the buds mature into fibrous plugs composed largely of fibronectin and a type of collagen.3PubMed Central. Intra-alveolar fibrosis of idiopathic bronchiolitis obliterans-organizing pneumonia. Cell-matrix patterns. Because this matrix is loose rather than dense scar tissue, the plugs can often be reabsorbed once inflammation is controlled, which is the biological reason corticosteroids work so well.
Causes and Triggers
When no identifiable cause is found, the condition is labeled cryptogenic (meaning “of unknown origin”), and this idiopathic form is the most common type.4Archives of Internal Medicine. Bronchiolitis Obliterans Organizing Pneumonia But organizing pneumonia can also arise as a secondary reaction to a wide range of insults. The main categories include:
- Infections: Bacterial, viral, and fungal lung infections can all trigger the organizing pneumonia pattern. COVID-19 has emerged as a recognized viral trigger, with studies documenting persistent organizing pneumonia in patients whose respiratory symptoms and lung infiltrates lingered for weeks after the virus itself had cleared.5PubMed Central. The Hidden Pandemic of COVID-19-Induced Organizing Pneumonia
- Medications: Chemotherapy agents, certain antibiotics, antiarrhythmic drugs, and immunosuppressive agents have all been linked to drug-induced interstitial lung disease, including the organizing pneumonia pattern.6PubMed Central. Drug induced interstitial lung disease.
- Radiation therapy: BOOP can develop within the first year after chest radiation, especially in women treated for breast cancer, and the inflammation sometimes extends beyond the radiation field into the opposite lung.7PubMed. Post-Breast Cancer Radiotherapy Bronchiolitis Obliterans Organizing Pneumonia
- Autoimmune diseases: Connective tissue diseases, particularly rheumatoid arthritis, are a well-documented association. In one institutional series of 21 patients with organizing pneumonia linked to rheumatoid arthritis, about two-thirds developed it during follow-up for their arthritis, while some developed it even before joint symptoms appeared.8PubMed Central. Organizing Pneumonia in Rheumatoid Arthritis Patients: A Case-Based Review
- Organ transplantation: The organizing pneumonia pattern has been recognized in lung transplant recipients, where it can represent a form of rejection or a nonspecific response to injury.9PubMed. Bronchiolitis obliterans organizing pneumonia-like reactions: a nonspecific response or an atypical form of rejection or infection in lung allograft recipients?
This wide range of triggers is part of what makes the diagnosis tricky. Organizing pneumonia is essentially a lung reaction pattern, not a single disease with a single cause. When a trigger is identified and removed, the secondary form can sometimes resolve faster or more completely, especially when the offending medication is stopped.
How Symptoms Present
BOOP typically begins with a subacute illness that feels a lot like a respiratory infection that won’t go away. Dry cough and shortness of breath lasting two weeks to two months are the most characteristic complaints.10PubMed Central. Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review Many patients also report a flu-like feeling with fever and general malaise. Crackles on lung examination are found in roughly two-thirds of patients.4Archives of Internal Medicine. Bronchiolitis Obliterans Organizing Pneumonia Lab work often shows an elevated erythrocyte sedimentation rate, a nonspecific marker of inflammation. Coughing up blood is rare, though it has been reported occasionally.
One reason BOOP is frequently misdiagnosed initially is that the symptoms mimic community-acquired pneumonia almost perfectly. The typical story involves a patient who gets treated with one or two courses of antibiotics for a supposed bacterial infection that never fully clears. When the infiltrates on chest X-ray persist despite antibiotics, the clinician starts to suspect something else is going on. That delay of weeks to months before the correct diagnosis is common and, while frustrating, is understandable given how generic the symptoms are.
How Doctors Reach the Diagnosis
CT scans of the chest are usually the first step that raises suspicion. The most common imaging findings are ground-glass opacities (hazy areas in the lungs) and consolidation (denser white patches), found in about 90% and 87% of patients, respectively, in one series. These tend to cluster along the lung periphery or along the airways, and they favor the middle and lower lung zones.11PubMed. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications A distinctive feature called the “reversed halo sign,” which looks like a ring of dense consolidation surrounding a center of ground-glass haze, appears in a meaningful minority of cases and strongly suggests organizing pneumonia when it is present.12Radiol Bras. Reversed halo sign on chest computed tomography: a retrospective analysis of 286 cases Another clue that sometimes appears on serial imaging is migration of the infiltrates: patches that appear, shrink, or move to different parts of the lung over weeks.
Bronchoalveolar lavage, a procedure that washes fluid through a section of the lung and collects it for analysis, produces a characteristic “colorful” cell mix. In BOOP patients, the lavage fluid typically shows increases in lymphocytes, neutrophils, eosinophils, and mast cells all at once, along with a decreased ratio of certain immune cell subtypes.13PubMed. Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage A separate study found elevated lymphocytes in about three-quarters of BOOP patients and elevated eosinophils in about 60%.14PubMed. Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis This mixed-cell pattern is suggestive but not definitive on its own.
Definitive diagnosis typically requires a lung biopsy showing the Masson bodies described earlier. Transbronchial biopsies performed through a bronchoscope can sometimes capture the tissue plugs, but in ambiguous cases, a surgical lung biopsy provides a larger sample and more diagnostic certainty. Doctors weigh the invasiveness of biopsy against how confident they already are from imaging and lavage findings. In a patient with classic symptoms, classic CT findings including migratory infiltrates, and the right lavage pattern, some clinicians proceed to a treatment trial with corticosteroids rather than biopsy, watching for the brisk response that further supports the diagnosis.
Treatment With Corticosteroids
Oral corticosteroids, typically prednisone, are the standard first-line therapy. A systematic review found that most patients started on systemic corticosteroids showed a favorable initial response, including partial or complete resolution of symptoms and imaging abnormalities. In one included series, full resolution occurred in about two-thirds of treated patients; in another, resolution was seen in all steroid-treated patients.15PubMed Central. Systematic Review of Systemic Corticosteroids for Treatment of Organizing Pneumonia The typical regimen begins with a moderate-to-high dose that is gradually tapered over several months. No single dosing protocol has been standardized, and practices vary among institutions in terms of starting dose and taper speed.
The dramatic initial response is one of the features that distinguishes organizing pneumonia from more worrisome interstitial lung diseases. Patients who feel terrible on antibiotics often report noticeable improvement within days of starting steroids, and follow-up imaging can show clearing of the infiltrates over weeks. That speed of improvement is itself a diagnostic clue.
When corticosteroids are ineffective or contraindicated, there are limited alternatives. Low-dose methotrexate has been used successfully in case reports, achieving complete remission in at least one patient who received weekly intravenous doses.16PubMed. Successful treatment of bronchiolitis obliterans organizing pneumonia with low-dose methotrexate in a patient with Hodgkin’s disease Other immunosuppressive agents, including azathioprine and cyclophosphamide, have been reported in small series, but none have been studied in controlled trials. For secondary cases, addressing the underlying trigger is often just as important as anti-inflammatory treatment.
Relapse Is Common
The biggest frustration with BOOP treatment is that it comes back with uncomfortable frequency. Across studies, roughly a quarter to a third of patients experience one or more relapses, and that rate climbs to about 36% among those treated with corticosteroids. Most relapses happen during steroid tapering or shortly after steroids are stopped.15PubMed Central. Systematic Review of Systemic Corticosteroids for Treatment of Organizing Pneumonia Several factors appear to raise relapse risk. In one series, patients who had bilateral shadow patterns on imaging, traction bronchiectasis, or only partial remission after initial steroid treatment were more likely to relapse.17PubMed Central. Predictive factors for relapse of cryptogenic organizing pneumonia There is also a suggestion that patients with an associated underlying disease relapse more often than those with truly idiopathic BOOP, though small sample sizes make that link hard to confirm statistically.18PubMed. Factors related to the relapse of bronchiolitis obliterans organizing pneumonia
The good news is that relapses generally respond to restarting or bumping up the steroid dose, so they are more of a management headache than a sign that the disease is getting worse. Doctors often slow the taper or extend the overall treatment duration in patients who relapse. Long-term prognosis remains favorable for most patients with idiopathic BOOP, though the months of treatment and potential for repeated courses take a genuine toll on quality of life.
The Toll on Daily Life
Case reports and reviews have documented that the combined burden of BOOP symptoms and steroid side effects can be severe. One detailed account of a post-radiotherapy BOOP patient described a three-year illness course during which the patient dealt not only with cough, fever, shortness of breath, and fatigue from the disease itself but also with fluid retention, muscle weakness, insomnia, weight gain, and the cushingoid facial changes caused by prolonged steroid use. Tapering off steroids then introduced its own withdrawal symptoms, including low blood pressure and worsening shortness of breath.19The Oncologist. Systematic Review of Postradiotherapy Bronchiolitis Obliterans Organizing Pneumonia in Women With Breast Cancer That case is on the extreme end, but even straightforward courses involve months of prednisone with its attendant side effects. If you or someone you know is dealing with BOOP, it is worth having a frank conversation with the treating physician about strategies to minimize steroid-related complications, including calcium and vitamin D supplementation, blood sugar monitoring, and bone density screening on longer courses.
The COVID-19 Connection
The COVID-19 pandemic brought organizing pneumonia into sharper focus. Since early in the pandemic, clinical, radiological, and histopathological studies have documented that organizing pneumonia can develop as a consequence of SARS-CoV-2 infection. This post-COVID organizing pneumonia causes lingering shortness of breath, impaired lung function, and imaging abnormalities persisting for at least five weeks after initial symptoms.5PubMed Central. The Hidden Pandemic of COVID-19-Induced Organizing Pneumonia In some patients recovering from COVID pneumonia, lung infiltrates and respiratory symptoms persisted for weeks after the virus had cleared, leading to biopsy-confirmed organizing pneumonia.20PubMed Central. Persistent Pneumonic Consolidations due to Secondary Organizing Pneumonia in a Patient Recovering from COVID-19 Pneumonia: A Case Report and Literature Review
This matters for anyone who had a COVID infection that seemed to resolve but left behind a persistent cough and shortness of breath. Many of these patients are told they have “long COVID” in a vague sense, but some fraction of them may have organizing pneumonia that is treatable with steroids. The clinical challenge is distinguishing post-COVID organizing pneumonia from other causes of lingering lung inflammation without resorting to biopsy in every patient. CT findings, the trajectory of symptoms, and the response to a steroid trial all factor into that decision.
BOOP in Children
Organizing pneumonia is predominantly an adult disease, but it does occur in children and can look different in that population. In a report of two adolescent boys with idiopathic BOOP, neither had respiratory symptoms or signs of infection. Their lung function tests showed only slight decreases, and the diagnosis was made after serial chest X-rays revealed migratory infiltrates that prompted bronchoscopy and biopsy. Both were managed with observation alone, without steroids, for three to four years.21Pediatric Pulmonology. Idiopathic bronchiolitis obliterans organizing pneumonia (idiopathic BOOP) in childhood That asymptomatic, watchful-waiting scenario contrasts sharply with the typical adult presentation.
In children with cancer, BOOP has been identified after chemotherapy, sometimes appearing as unexpected pulmonary infiltrates or nodules on imaging done for other reasons. Open lung biopsy confirmed the diagnosis in a series of four pediatric cancer patients, and the condition was described as “usually innocuous” compared to the more severe pure bronchiolitis obliterans.22PubMed. Bronchiolitis obliterans-organizing pneumonia (BOOP) in children with malignant disease There have even been rare pediatric cases attributed to gastroesophageal reflux, where chronic acid aspiration triggered the organizing pneumonia pattern. In two reported children, treating the reflux alongside a course of corticosteroids resolved the lung disease.23Pediatrics. Bronchiolitis Obliterans Organizing Pneumonia Due to Gastroesophageal Reflux
Rheumatoid Arthritis and Organizing Pneumonia
The link between rheumatoid arthritis and BOOP deserves its own discussion because it runs in both directions. Organizing pneumonia can develop as a complication of the joint disease itself, as a side effect of the drugs used to treat it, or sometimes as the very first sign of rheumatoid arthritis before any joint symptoms appear.24PubMed Central. Organising pneumonia – the first manifestation of rheumatoid arthritis Interstitial lung disease is one of the recognized extra-articular features of rheumatoid arthritis, and the organizing pneumonia pattern is one of several forms it can take.25Journal of Rheumatic Diseases. Bronchiolitis Obliterans with Organizing Pneumonia (BOOP) in a Patient with Rheumatoid Arthritis For rheumatoid arthritis patients who develop a new cough or unexplained shortness of breath, this connection is worth raising with their rheumatologist, especially if they recently started or changed a biologic or disease-modifying drug.
Emerging Biomarkers for Tracking Relapse
One of the active research questions is whether a blood or lung-fluid marker can predict who will relapse, saving those patients from the cycle of tapering steroids, relapsing, and restarting. A retrospective study found that patients with elevated levels of surfactant protein D (SP-D), a substance produced by lung cells, had significantly more relapses than those with normal SP-D levels. In that study, all six relapses occurred in the high-SP-D group, while no patients with normal levels relapsed.26PubMed Central. A retrospective clinical research of relapsed organizing pneumonia The sample sizes are small and the finding needs validation in larger studies, but SP-D is the kind of simple, measurable marker that could eventually help clinicians make smarter decisions about how aggressively and how long to treat. For now, the practical approach remains clinical: symptoms, imaging, and lung function tests guide the taper, and any worsening prompts reassessment.